SCHEMBL954180

SCHEMBL954180

FC(c1cccc(N(c2ccccc2)c2ccccc2)n1)(c1cccc(N(c2ccccc2)c2ccccc2)n1)c1cccc(N(c2ccccc2)c2ccccc2)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.36
TDP1 Q9NUW8 3/20 0.36
PGK1 P00558 1/20 0.35
PGK2 P07205 1/20 0.35
POLB P06746 1/20 0.35
MAPT P10636 2/20 0.32
KDM4E B2RXH2 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
APOBEC3G Q9HC16 1/20 0.31
RORC P51449 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
NR1H3 Q13133 1/20 0.31
HSD17B10 Q99714 1/20 0.30
OPRM1 P35372 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17032805 0.80 ALDH1A1 (0.46) ALDH1A1TDP1POLBMAPTKDM4E
SCHEMBL13670533 0.77 MAPT (0.32) ALDH1A1TDP1POLBMAPTRORC
SCHEMBL13231057 0.76 ENPP1 (0.38) TDP1KDM4EHSD17B10OPRM1KCNH2
SCHEMBL13231264 0.75 ENPP1 (0.37) TDP1KDM4EHSD17B10OPRM1KCNH2
SCHEMBL5109003 0.74 TDP1 (0.42) ALDH1A1TDP1POLBMAPTKDM4E
SCHEMBL954531 0.74 SMN1; SMN2 (0.33) ALDH1A1TDP1POLBL3MBTL1
SCHEMBL954785 0.73 MEN1 (0.43) ALDH1A1TDP1POLBMAPTKDM4E
SCHEMBL23351082 0.72 MAPT (0.41) ALDH1A1TDP1POLBMAPTKDM4E
SCHEMBL26028769 0.72 ALDH1A1 (0.45) ALDH1A1TDP1POLBMAPTKDM4E
SCHEMBL13230749 0.72 ENPP1 (0.37) TDP1MAPTKDM4EL3MBTL1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8617723-B2 Metal complexes MERCK PATENT GMBH (DE) 2013-12-31 US disclosed
US-20110012100-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2011-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110012100-A1 METAL COMPLEXES AP1M1, AP3M1, SOD1 ALDH1A1 1419/4885TDP1 2607/4885PGK1 2861/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.